Clinical Trial Update: Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating lymphodepletion followed by adoptive cell therapy with high-dose interleukin-2 in adolescent and young adult patients with soft tissu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2024-06-12